The enhancement apoptosis of osteosarcoma mesenchymal stem cells co-cultivation with peripheral blood mononuclear cells sensitized by secretome and granulocyte macrophage colony-stimulating factor

• Main Authors: Hizbillah Yazid, -, Mouli Edward, -, M. Hardian Basuki, -, Yunus Abdul Bari, -, Fedik Abdul Rantam, -
• Format: Article PeerReviewed
• Language: English; English; English; English
• Published: Wolters Kluwer Medknow Publications 2020
• Subjects: R Medicine (General); RD701-811 Orthopedic surgery
• Online Access: https://repository.unair.ac.id/113414/1/C-02_Bukti%20Korespondensi%20-%20The%20Enhancement%20Apoptosis%20of.pdf; https://repository.unair.ac.id/113414/2/C-02_Article_The%20enhancement%20apoptosis_compressed.pdf; https://repository.unair.ac.id/113414/3/C-02_Turnitin%2012_The%20enhancement%20apoptosis.pdf; https://repository.unair.ac.id/113414/4/C-02_Validasi%20Kadep%20dan%20Peer%20Reviewer%20-%20The%20Enhancement%20of%20Apopotosis.pdf; https://repository.unair.ac.id/113414/; https://www.japtr.org/article.asp?issn=2231-4040;year=2020;volume=11;issue=4;spage=213;epage=219;aulast=Mahyudin
• Institution: Universitas Airlangga

The advanced, metastasis, and reccurent of osteosarcoma (OS) patients have a poor prognosis postaggresive surgery and chemotherapy. Peripheral blood mononuclear cells (PBMCs) as cell-based immunotherapy may successful in the OS treatment. To investigate the enhancement apoptosis of OS-mesenchymal stem cells (OS-MSCs) co-cultivated with PBMCs sensitized using the secretome and granulocyte macrophage colony-stimulating factor (GMCSF). This true experimental study with posttest only control group design and in vitro study. The sample was cultured OS-MSCs which confirmed by Cluster of Differentiation-133 using immunocytochemistry (ICC) and histopathology analysis. The sample divided into six groups accordingly: OS-MSC, OS-MSC + PMBC, OS-MSC + PMBC + Secretome, OS-MSC + PMBC + GMCSF, OS-MSC + PBMC + Secretome + GMCSF (n = 5/N = 30). The enhancement of OS-MSCs apoptosis was analyzed through Interleukin-2 (IL-2) level through the Enyzme-Linked Immunosorbent Assay examination, expression of Signal Transducers and Activators of Transcription (STAT)-3 and caspase-3 by ICC. One-way analysis of variance test and Tukey Honestly Significant Difference to analyze the difference between the groups (P < 0.05). The highest of IL-2 level was found in the PBMC + Secretome + GMCSF group. The highest expression of caspase-3 was found in OS-MSC + PBMC + Secretome + GMCSF group with significant different between groups (P < 0.05). There was insignificant difference of STAT-3 epxression and IL-2 level between groups (P > 0.05). The co-cultivation of OS-MSCs and PBMSCs activated using secretome and GMCSF has a great ability to enhance OS-MSCs apoptosis.